| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-14 |
| filingDate |
2019-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_867742314fcfebd9cf8cb8197534660e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_401636b6809671582eb37876259ff01f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9dfcbe9612d47447a122eb63c63ec2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b685bac6d96893fadb329caa72390eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2de4f78e00fd505ca1854647fd6e3cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83eabb4e7d5cddf17369db434e8b15c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fab3720521dbe3f83bb172e3e74c222 |
| publicationDate |
2021-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2019309727-A1 |
| titleOfInvention |
NLRP3 inflammasome inhibitors |
| abstract |
The present invention relates to novel thienopyrrolotriazinacetamide compounds of Formula (I): wherein R |
| priorityDate |
2018-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |